Bridgefront Capital’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Buy
31,649
+24,358
+334% +$951K 0.44% 51
2026
Q1
$258K Sell
7,291
-90
-1% -$2.79K 0.06% 429
2025
Q4
$207K Buy
+7,381
New +$221K 0.05% 451
2025
Q2
Sell
-23,346
Closed -$771K 589
2025
Q1
$771K Buy
+23,346
New +$761K 0.22% 137
2021
Q3
Sell
-13,597
Closed -$333K 315
2021
Q2
$333K Buy
+13,597
New +$302K 0.13% 312
2021
Q1
Sell
-22,510
Closed -$449K 653
2020
Q4
$449K Buy
+22,510
New +$412K 0.15% 243

Other funds holding ALKS

Bridgefront Capital's ALKS Position: Q2 2026 in Review

Bridgefront Capital increased its Alkermes (ALKS) stake by 334% in Q2 2026, buying an estimated $951K and bringing the position to 31,649 shares worth $1.66M. The position accounts for 0.44% of the portfolio, ranked #51.

Bridgefront Capital first reported a position in ALKS in Q4 2020 and has held it in 6 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Bridgefront Capital held 31,649 shares of Alkermes worth $1.66M as of Q2 2026.
  • Bridgefront Capital bought 24,358 Alkermes shares in Q2 2026, an estimated $951K.
  • Alkermes made up 0.44% of Bridgefront Capital's portfolio in Q2 2026, its #51 holding.
  • Bridgefront Capital first reported a position in Alkermes in Q4 2020 and has held it in 6 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.